Literature DB >> 9707218

Ethical challenges in stroke research.

H Slyter1.   

Abstract

BACKGROUND: Ethical issues are a critical consideration in the design and conduct of clinical research. SUMMARY OF REVIEW: A number of completed trials of proposed stroke treatments raise classical ethical issues in challenging ways. The combination of acutely ill and vulnerable patients, the use of potentially toxic drugs, and very short time frames for decision making and drug administration demand an especially careful evaluation of risk and benefit, the process of consent, and the permissible treatment of control patients.
CONCLUSIONS: The study of acute stroke treatments may require more complex safeguards than other neuroclinical trials.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1998        PMID: 9707218     DOI: 10.1161/01.str.29.8.1725

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

Review 1.  Thrombolytic therapy for stroke: a review with particular reference to elderly patients.

Authors:  K W Muir; M Roberts
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

2.  IRB Member Judgments of Decisional Capacity, Coercion, and Risk in Medical and Psychiatric Studies.

Authors:  Rebecca Luebbert; Raymond C Tait; John T Chibnall; Teresa L Deshields
Journal:  J Empir Res Hum Res Ethics       Date:  2008-03       Impact factor: 1.742

3.  Changes in stroke research productivity: A global perspective.

Authors:  Daniel S Chow; Jason S Hauptman; Tony T Wong; Nestor R Gonzalez; Neil A Martin; Angella A Lignelli; Michael W Itagaki
Journal:  Surg Neurol Int       Date:  2012-02-15

4.  Effect of informed consent on patient characteristics in a stroke thrombolysis trial.

Authors:  Götz Thomalla; Florent Boutitie; Jochen B Fiebach; Claus Z Simonsen; Norbert Nighoghossian; Salvador Pedraza; Robin Lemmens; Pascal Roy; Keith W Muir; Christoph Heesen; Martin Ebinger; Ian Ford; Bastian Cheng; Tae-Hee Cho; Josep Puig; Vincent Thijs; Matthias Endres; Jens Fiehler; Christian Gerloff
Journal:  Neurology       Date:  2017-08-25       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.